News ·

Neurawave launches Relief aHead and Relivia in Chile

After months of work, Neurawave has launched its brand Relief aHead and the product Relivia in Chile, its first market outside Sweden.

Today is a big day at Neurawave. After months of work, we have officially launched our brand Relief aHead and the product Relivia in Chile. Relivia is a drug-free option for migraine that uses external trigeminal nerve stimulation (e-TNS).

Migraine affects millions of people in Chile, and according to the WHO it is the third most common cause of disability worldwide. Yet access to effective, drug-free alternatives is still limited.

We want to change that.

Relivia is developed and manufactured in Sweden and builds on more than 30 years of independent clinical research. In 2026 we are also running clinical studies together with Karolinska.

Chile is our first step outside Sweden, and only the beginning. We are proud, excited and ready.

Read more at reliefahead.com.

About Neurawave

Neurawave AB is a Swedish company in Kalmar that develops Relivia, a device for people living with migraine, and the Relief aHead app. Relivia is sold in Chile under the Relief aHead brand.

Press kit

Press contact

press@reliefahead.com · neurawave.se
We reply during Swedish office hours, Monday to Friday.